|
Volumn 36, Issue 9, 1995, Pages 389-394
|
Additive benefits of EFAs in dogs with atopic dermatitis after partial response to antihistamine therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHLORPHENIRAMINE;
CLEMASTINE;
CYPROHEPTADINE;
ESSENTIAL FATTY ACID;
HISTAMINE H1 RECEPTOR ANTAGONIST;
HYDROXYZINE;
ANIMAL;
ANIMAL DISEASE;
ARTICLE;
ATOPIC DERMATITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOG;
DOG DISEASE;
DRUG COMBINATION;
DRUG POTENTIATION;
FEMALE;
HOSPITALIZATION;
MALE;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
STANDARD;
ANIMALS;
CHLORPHENIRAMINE;
CLEMASTINE;
CYPROHEPTADINE;
DERMATITIS, ATOPIC;
DOG DISEASES;
DOGS;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
FATTY ACIDS, ESSENTIAL;
FEMALE;
HISTAMINE H1 ANTAGONISTS;
HYDROXYZINE;
MALE;
SEVERITY OF ILLNESS INDEX;
|
EID: 0029366420
PISSN: 00224510
EISSN: 17485827
Source Type: Journal
DOI: 10.1111/j.1748-5827.1995.tb02961.x Document Type: Article |
Times cited : (29)
|
References (24)
|